Can a high absolute arachidonic acid pool drive inflammatory mediator production even when the AA:EPA ratio looks optimal?

The absolute concentration of arachidonic acid (AA) within tissue and plasma significantly dictates the potential for inflammatory mediator production, a process that can occur independently of its ratio to eicosapentaenoic acid (EPA). While the AA:EPA ratio is a standard clinical marker for inflammatory balance, it can be mathematically misleading if both fatty acids are present in high absolute concentrations.

Clinical and Mechanistic Evidence

The relationship between fatty acid pools and inflammation is governed by enzymatic competition and substrate availability:

• Substrate-Driven Production: Arachidonic acid serves as the primary precursor for 2-series prostaglandins (e.g., PGE2) and 4-series leukotrienes (e.g., LTB4) via the cyclooxygenase (COX) and lipoxygenase (LOX) pathways. Research in human neutrophils and monocytes indicates that the absolute concentration of free AA—released from membrane phospholipids by phospholipase A2 (PLA2)—is a key rate-limiting factor. Higher absolute AA pools provide more substrate for these enzymes, leading to robust inflammatory signaling regardless of the relative amount of EPA present.
• Enzymatic Kinetics and Mass Action: EPA and AA compete for the same COX and LOX enzymes. While EPA acts as a competitive inhibitor and produces less-inflammatory 3-series mediators, a high absolute concentration of AA can overcome this inhibition through the principle of mass action. In subjects where both fatty acids are elevated, the potential for pro-inflammatory eicosanoid production remains high even if the AA:EPA ratio appears "optimal" (e.g., <1.5 or 2:1).
• Systemic Markers: Clinical data show that high absolute AA levels correlate with increased systemic inflammatory markers such as C-reactive protein (CRP), TNF-α, and IL-6. If systemic inflammation is high (CRP ≥1.0 mg/L), a moderate or "optimal" AA:EPA ratio may be insufficient to counteract the absolute inflammatory burden driven by a large AA pool.

Practical Considerations

For individuals monitoring inflammatory status, the absolute size of the AA pool is as critical as the ratio. A favorable ratio achieved through high-dose omega-3 supplementation may mask a high absolute AA level, which can still be triggered by stimuli that activate PLA2, such as acute injury or metabolic stress.

Bottom line

A higher absolute arachidonic acid pool increases the substrate available for pro-inflammatory mediator production through "mass action" kinetics. This can drive inflammatory signaling even when the AA:EPA ratio is optimal, particularly if total substrate levels for both fatty acids are high.